Suppr超能文献

维生素D补充剂长期研究中的高钙血症、高钙尿症和肾结石:一项系统评价和荟萃分析

Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis.

作者信息

Malihi Zarintaj, Wu Zhenqiang, Stewart Alistair W, Lawes Carlene Mm, Scragg Robert

机构信息

School of Population Health, University of Auckland, Auckland, New Zealand.

School of Population Health, University of Auckland, Auckland, New Zealand

出版信息

Am J Clin Nutr. 2016 Oct;104(4):1039-1051. doi: 10.3945/ajcn.116.134981. Epub 2016 Sep 7.

Abstract

BACKGROUND

Vitamin D supplementation is increasingly being used in higher doses in randomized controlled trials (RCTs). However, adverse events from very large annual doses of vitamin D have been shown in 2 RCTs, whereas in a third RCT, low-dose vitamin D, with calcium supplements, was shown to increase kidney stone risk.

OBJECTIVE

We analyzed the side effects related to calcium metabolism in RCTs, specifically hypercalcemia, hypercalciuria, and kidney stones, in participants who were given vitamin D supplements for ≥24 wk compared with in subjects in the placebo arm.

DESIGN

The following 3 main online databases were searched: Ovid Medline (PubMed), EMBASE, and the Cochrane Library. Software was used for the meta-analysis.

RESULTS

A total of 48 studies with 19,833 participants were identified, which reported ≥1 of the following side effects: hypercalcemia, hypercalciuria, or kidney stones. Of these studies, kidney stones were reported in only 9 trials with a tendency for fewer subjects reporting stones in the vitamin D arm than in the placebo arm (RR: 0.66, 95% CI: 0.41, 1.09; P = 0.10). In 37 studies, hypercalcemia was shown with increased risk shown for the vitamin D group (RR: 1.54; 95% CI: 1.09, 2.18; P = 0.01). Similar increased risk of hypercalciuria was shown in 14 studies for the vitamin D group (RR: 1.64; 95% CI: 1.06, 2.53; P = 0.03). In subgroup analyses, it was shown that the effect of vitamin D supplementation on risk of hypercalcemia, hypercalciuria, or kidney stones was not modified by baseline 25-hydroxyvitamin D, vitamin D dose and duration, or calcium co-supplementation.

CONCLUSIONS

Long-term vitamin D supplementation resulted in increased risks of hypercalcemia and hypercalciuria, which were not dose related. However, vitamin D supplementation did not increase risk of kidney stones. Additional large RCTs of long-term vitamin D supplementation are required to confirm these findings.

摘要

背景

在随机对照试验(RCT)中,维生素D补充剂的使用剂量越来越高。然而,两项RCT显示了每年大剂量维生素D会引发不良事件,而在第三项RCT中,低剂量维生素D与钙补充剂一起使用会增加肾结石风险。

目的

我们分析了RCT中与钙代谢相关的副作用,特别是高钙血症、高钙尿症和肾结石,这些副作用出现在接受维生素D补充剂≥24周的参与者中,并与安慰剂组的受试者进行比较。

设计

检索了以下3个主要在线数据库:Ovid Medline(PubMed)、EMBASE和Cochrane图书馆。使用软件进行荟萃分析。

结果

共确定了48项研究,涉及19833名参与者,这些研究报告了以下至少一种副作用:高钙血症、高钙尿症或肾结石。在这些研究中,只有9项试验报告了肾结石,维生素D组报告结石的受试者倾向于比安慰剂组少(RR:0.66,95%CI:0.41,1.09;P = 0.10)。在37项研究中,显示维生素D组高钙血症风险增加(RR:1.54;95%CI:1.09,2.18;P = 0.01)。在14项研究中,维生素D组也显示出类似的高钙尿症风险增加(RR:1.64;95%CI:1.06,2.53;P = 0.03)。在亚组分析中,结果显示补充维生素D对高钙血症、高钙尿症或肾结石风险的影响不受基线25-羟维生素D、维生素D剂量和持续时间或钙共同补充的影响。

结论

长期补充维生素D会增加高钙血症和高钙尿症的风险,且与剂量无关。然而,补充维生素D并未增加肾结石风险。需要更多长期补充维生素D的大型RCT来证实这些发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验